Phase 1 Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)

Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis

Regeneron Pharmaceuticals132 enrolled3 locationsNCT06836609

Recruiting

Phase 1Phase 2

Study of TGM-312-SC01 in Healthy Participants and Adults With MASH

Healthy ParticipantsMASH - Metabolic Dysfunction-Associated Steatohepatitis

Tangram Therapeutics Plc99 enrolled1 locationNCT07427680

Recruiting

Phase 1

ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants

Metabolic Dysfunction-Associated Steatohepatitis

Eccogene72 enrolled1 locationNCT07334080